Richard Bayliss - Publications, H-index & Citations

Richard Bayliss

University of Leeds

56H指数

347论文数

9.9K被引数

收录论文 90

发表时间

Mechanistic design of cell-penetrating disruptors for phospho-dependent TACC3-CHC interaction 磷酸依赖性TACC3-CHC相互作用的细胞穿透性破坏剂的作用机制设计

Structure

IF4.3

2026-04-27

OAAI

Vanda Gunning; Matthew Batchelor; Krista K. Alexander; Martin Walko; Taylor C. Dill; Selena G. Burgess; Stephen J. Royle; Eileen J. Kennedy; Richard Bayliss

Modular Rh-Catalyzed Synthesis and Biological Profiling of Diverse Pentafluorobenzenesulfonamide Reactive Fragments 模块化铑催化合成及不同五氟苯磺酰胺活性片段的生物表征

Chemistry - A European Journal

IF3.7

2026-04-10

OAAI

Julian Chesti; Jennifer A. Miles; George J. Wade; Scott Grossman; George W. Preston; Richard Bayliss; Stuart L. Warriner; Megan H. Wright; Adam Nelson

FPHC Wellbeing Charter: The ‘Whys’ and ‘Hows’ of the Charter FPHC 健康福祉宪章：宪章的“原因”与“方法”

Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine

IF0

2025-11-24

OAAI

Sarah Morton; Katy Surman; Richard Bayliss; Heather Storey; Emma Gray; Andrew Gant; Alistair Morris; Anna Forbes; Stephanie Cowan; Elizabeth Stevenson; Pamela Hardy; Richard Williams

RAF inhibitors activate the integrated stress response by direct activation of GCN2 RAF抑制剂通过直接激活GCN2来激活整合应激反应

Nature Communications

IF15.7

2025-11-17

OAAI

Rebecca Gilley; Andrew M. Kidger; Graham Neill; Eve Morrison; Paul Severson; Dominic P. Byrne; Niall S. Kenneth; Gideon Bollag; Chao Zhang; Taiana Maia de Oliveira; Patrick A. Eyers; Richard Bayliss; Glenn R. Masson; Simon J. Cook

Molecular and clinical characteristics of ROS1 Fusion Variants in ROS1-rearranged Cancers: A Defined Role of Fusion Partners and Breakpoints of ROS1 ROS1融合变体的分子和临床特征：ROS1重排癌中融合伴侣和断点的明确作用

European Journal of Cancer

IF7.1

2025-11-02

PREAI

Ji-Seon Jeong; Yeokyeong Shin; Shinkyo Yoon; Deokhoon Kim; Josephina Sampson; Richard Bayliss; Jene Choi

Structural characterization and inhibition of the interaction between ch-TOG and TACC3 结构表征及ch-TOG与TACC3之间相互作用的抑制

JOURNAL OF CELL BIOLOGY

IF6.4

2025-03-19

OAAI

Shelford, James; Burgess, Selena G.; Rostkova, Elena; Richards, Mark W.; Larocque, Gabrielle; Sampson, Josephina; Tiede, Christian; Fielding, Alistair J.; Daviter, Tina; Tomlinson, Darren C.; Calabrese, Antonio N.; Pfuhl, Mark; Bayliss, Richard

Constrained TACC3 peptidomimetics for a non-canonical protein-protein interface elucidate allosteric communication in Aurora-A kinase

CHEMICAL SCIENCE

IF7.4

2025-01-01

OAAI

Gimenez, Diana; Walko, Martin; Miles, Jennifer A.; Bayliss, Richard; Wright, Megan H.; Wilson, Andrew J.

Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK-driven non-small cell lung cancer

CELL DEATH & DISEASE

IF9.6

2024-12-18

OAAI

Sampson, Josephina; Ju, Hyun-min; Zhang, Nan; Yeoh, Sharon; Choi, Jene; Bayliss, Richard

Exploring the dynamics and interactions of the N-myc transactivation domain through solution nuclear magnetic resonance spectroscopy

BIOCHEMICAL JOURNAL

IF4.3

2024-10-21

OAAI

Rejnowicz, Ewa; Batchelor, Matthew; Leen, Eoin; Ahangar, Mohd Syed; Burgess, Selena G.; Richards, Mark W.; Kalverda, Arnout P.; Bayliss, Richard

CEP192 localises mitotic Aurora-A activity by priming its interaction with TPX2

EMBO JOURNAL

IF8.3

2024-09-26

OAAI

Holder, James; Miles, Jennifer A.; Batchelor, Matthew; Popple, Harrison; Walko, Martin; Yeung, Wayland; Kannan, Natarajan; Wilson, Andrew J.; Bayliss, Richard; Gergely, Fanni

Remembering Andrew Fry (1966-2024)

JOURNAL OF CELL SCIENCE

IF3.6

2024-09-06

OAAI

Bayliss, Richard; Fry, Tim; Mahen, Robert; Shackleton, Sue; Tanaka, Kayoko

HER3 overexpression: a predictive marker for poor prognosis in advanced ALK-positive non-small cell lung cancer treated with ALK inhibitors

TRANSLATIONAL LUNG CANCER RESEARCH

IF3.5

2024-02-01

OAAI

Kim, Meejeong; Ju, Hyun-min; Song, Ji-young; Sampson, Josephina; Bayliss, Richard; Choi, Jene

ALKing the flames of lung cancer immunosensitivity

MOLECULAR ONCOLOGY

IF4.5

2023-10-12

OAAI

Bayliss, Richard; Sarnowska, Elzbieta; Yeoh, Sharon; Sampson, Josephina

EML4-ALK biology and drug resistance in non-small cell lung cancer: a new phase of discoveries

MOLECULAR ONCOLOGY

IF4.5

2023-05-15

OAAI

Elshatlawy, Mariam; Sampson, Josephina; Clarke, Katy; Bayliss, Richard

MYC-C interacts with Aurora kinase A in Ewing sarcoma cells

CANCER RESEARCH

IF16.6

2023-04-04

PREAI

Mcnae, Molly; Burgess, Selena G.; Bayliss, Richard; Burchill, Susan A.

A point mutation in the kinase domain of CRK10 leads to xylem vessel collapse and activation of defence responses in Arabidopsis

JOURNAL OF EXPERIMENTAL BOTANY

IF5.7

2023-03-03

OAAI

Piovesana, Maiara; Wood, Ana K. M.; Smith, Daniel P.; Deery, Michael J.; Bayliss, Richard; Carrera, Esther; Wellner, Nikolaus; Kosik, Ondrej; Napier, Johnathan A.; Kurup, Smita; Matthes, Michaela C.

Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2022-08-01

OAAI

Arter, Chris; Trask, Luke; Ward, Sarah; Yeoh, Sharon; Bayliss, Richard

α-Helix stabilization by co-operative side chain charge-reinforced interactions to phosphoserine in a basic kinase-substrate motif

BIOCHEMICAL JOURNAL

IF4.3

2022-03-16

OAAI

Batchelor, Matthew; Dawber, Robert S.; Wilson, Andrew J.; Bayliss, Richard

EML4-ALK Variant 3 Promotes Mitotic Errors and Spindle Assembly Checkpoint Deficiency Leading to Increased Microtubule Poison Sensitivity

MOLECULAR CANCER RESEARCH

IF4.7

2022-02-25

OAAI

Lucken, Kellie; O'Regan, Laura; Choi, Jene; Sampson, Josephina; Pashley, Sarah L.; Bayliss, Richard; Khan, Sam; Fry, Andrew M.

Exploring the Conformational Landscape and Stability of Aurora A Using Ion-Mobility Mass Spectrometry and Molecular Modeling

JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY

IF2.7

2022-01-31

OAAI

Tomlinson, Lauren J.; Batchelor, Matthew; Sarsby, Joscelyn; Byrne, Dominic P.; Brownridge, Philip J.; Bayliss, Richard; Eyers, Patrick A.; Eyers, Claire E.

研究方向